- United States
- /
- Tobacco
- /
- NYSE:PM
Philip Morris International (NYSE:PM) Declares US$1.35 Dividend; Appoints New U.S. Communications Officer
Reviewed by Simply Wall St
Philip Morris International (NYSE:PM) recently announced a regular quarterly dividend of $1.35 per share and appointed Jody Sunna as the new U.S. Chief Communications Officer, reflecting the company's ongoing commitment to shareholder returns and strategic leadership. Over the last quarter, Philip Morris' stock price increased by 21%, a significant movement that may have been influenced by these affirmations coupled with the company's strong financial performance. During this period, the market faced volatility due to geopolitical tensions affecting broader indices, yet Philip Morris managed to post a positive return amidst these challenges, supporting the stock's resilience.
We've spotted 2 warning signs for Philip Morris International you should be aware of.
The recent boost in Philip Morris International’s shares by 21% in the last quarter may reflect investor confidence, partially driven by the announcement of a US$1.35 dividend per share and key leadership appointments. Over a longer five-year period, the company's total return, including dividends, reached a notable 220.66%. This indicates strong returns for investors. In comparison to the one-year U.S. market return of 11.7%, Philip Morris outperformed significantly. However, when viewed against the U.S. Tobacco industry, which posted a 30.8% return, Philip Morris' performance was also strong but not as high as the industry's.
This recent news could potentially impact revenue and earnings projections, especially considering the anticipated hurdles and opportunities linked to its smoke-free products like IQOS and ZYN. These developments underscore the importance of these product segments for future growth. Analysts have set a consensus price target of US$177.15 for the stock, slightly above the current share price of US$175.36. This suggests a moderate discount of around 3.77%. The market expectations reflected in these targets might adjust if Philip Morris continues to leverage its pricing strategy and operational efficiencies successfully. Investors should consider the possible variability due to regulatory and market conditions affecting smoke-free product growth.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
The New Payments ETF Is Live on NASDAQ:
Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.
Explore how this launch could reshape portfolios
Sponsored ContentNew: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:PM
Fair value second-rate dividend payer.
Similar Companies
Market Insights
Weekly Picks
THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

The Quiet Giant That Became AI’s Power Grid
Recently Updated Narratives
Deep Value Multi Bagger Opportunity

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Unicycive Therapeutics (Nasdaq: UNCY) – Preparing for a Second Shot at Bringing a New Kidney Treatment to Market (TEST)
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)
Trending Discussion
